COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins

Abstract

We have accumulated my own experience of management pregnant women with COVID-19 after assisted reproductive technologies (ART) receiving low molecular weight heparins (LMWH). All women suffered COVID-19 in mild form without respiratory failure and gave birth to healthy children. Our observations correspond to the data of world literature. Therefore, we want to draw the attention of the editors and the readers to the positive role of LMWH in the control of COVID-19.

Keywords

• covid-19
• novel coronavirus infection
• sars-cov-2
• low molecular weight heparins
• lmwh
• assisted reproductive technologies
• art
• in vitro fertilization
• ivf